WallStreetZenWallStreetZen

NASDAQ: ANGO
Angiodynamics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ANGO

Based on 2 analysts offering 12 month price targets for Angiodynamics Inc

Min Forecast
$15.00+53.37%
Avg Forecast
$15.50+58.49%
Max Forecast
$16.00+63.6%

Should I buy or sell ANGO stock?

Based on 2 analysts offering ratings for Angiodynamics Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ANGO's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ANGO as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ANGO stock forecasts and price targets.

ANGO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-07
lockedlocked$00.00+00.00%2025-01-09

1 of 1

Forecast return on equity

Is ANGO forecast to generate an efficient return?

Company
-3.93%
Industry
17.53%
Market
66.57%
ANGO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ANGO forecast to generate an efficient return on assets?

Company
-2.56%
Industry
12.67%
ANGO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ANGO earnings per share forecast

What is ANGO's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.24
Avg 2 year Forecast
-$0.18

ANGO revenue forecast

What is ANGO's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$305.0M+7.67%
Avg 2 year Forecast
$317.7M+12.14%
ANGO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ANGO revenue growth forecast

How is ANGO forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
5.9%
Industry
8.57%
Market
10%
ANGO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ANGO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ANGO vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
ANGO$9.78$15.50+58.49%Strong Buy
NYXH$7.47$14.50+94.11%Strong Buy
SMTI$28.41$49.50+74.23%Strong Buy
EMBC$9.64$13.00+34.85%Hold
OSUR$3.01$3.00-0.33%Hold
View Top Medical Stocks

Angiodynamics Stock Forecast FAQ

Is Angiodynamics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ANGO) stock is to Strong Buy ANGO stock.

Out of 2 analysts, 1 (50%) are recommending ANGO as a Strong Buy, 1 (50%) are recommending ANGO as a Buy, 0 (0%) are recommending ANGO as a Hold, 0 (0%) are recommending ANGO as a Sell, and 0 (0%) are recommending ANGO as a Strong Sell.

If you're new to stock investing, here's how to buy Angiodynamics stock.

What is ANGO's earnings growth forecast for 2026-2027?

(NASDAQ: ANGO) Angiodynamics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 17.51%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.72%.

Angiodynamics's earnings in 2025 is -$41,392,000.On average, 3 Wall Street analysts forecast ANGO's earnings for 2026 to be -$9,879,680, with the lowest ANGO earnings forecast at -$11,369,956, and the highest ANGO earnings forecast at -$8,121,397.

In 2027, ANGO is forecast to generate -$7,309,257 in earnings, with the lowest earnings forecast at -$7,309,257 and the highest earnings forecast at -$7,309,257.

What is ANGO's revenue growth forecast for 2026-2027?

(NASDAQ: ANGO) Angiodynamics's forecast annual revenue growth rate of 5.9% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10%.

Angiodynamics's revenue in 2025 is $283,320,000.On average, 3 Wall Street analysts forecast ANGO's revenue for 2026 to be $12,386,755,009, with the lowest ANGO revenue forecast at $12,283,613,265, and the highest ANGO revenue forecast at $12,543,497,975.

In 2027, ANGO is forecast to generate $12,901,651,592 in revenue, with the lowest revenue forecast at $12,901,651,592 and the highest revenue forecast at $12,901,651,592.

What is ANGO's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: ANGO) forecast ROA is -2.56%, which is lower than the forecast US Medical Instruments & Supplies industry average of 12.67%.

What is ANGO's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ANGO price target, the average ANGO price target is $15.50, with the highest ANGO stock price forecast at $16.00 and the lowest ANGO stock price forecast at $15.00.

On average, Wall Street analysts predict that Angiodynamics's share price could reach $15.50 by Apr 7, 2026. The average Angiodynamics stock price prediction forecasts a potential upside of 58.49% from the current ANGO share price of $9.78.

What is ANGO's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: ANGO) Angiodynamics's current Earnings Per Share (EPS) is -$1.01. On average, analysts forecast that ANGO's EPS will be -$0.24 for 2026, with the lowest EPS forecast at -$0.28, and the highest EPS forecast at -$0.20. In 2027, ANGO's EPS is forecast to hit -$0.18 (min: -$0.18, max: -$0.18).

What is ANGO's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: ANGO) forecast ROE is -3.93%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.